CD177 and lung disorder: In various lung diseases, the S100a8/S100a9 complex exacerbates inflammatory responses by activating multiple cell surface receptors and intracellular signaling pathways (including MAPK and NF-κB), thereby promoting the emission of inflammatory mediators and the recruitment of immune cells [33, 59].